Related Experiment Video
Updated: Apr 17, 2026

Isolation, Transfection, and Culture of Primary Human Monocytes
Published on: December 16, 2019
Coronary artery disease in patients with HIV infection
Amish A Patel1, Matthew J Budoff
1Los Angeles Biomedical Research Institute at Harbor-UCLA, 1124 W Carson St, Torrance, CA, 90502, USA.
Insights
Human immunodeficiency virus (HIV) infection increases the risk of early coronary artery disease due to chronic inflammation and antiretroviral therapy. Early detection and prevention strategies are crucial for managing cardiovascular risk in these patients.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Public Health
Background:
- Human immunodeficiency virus (HIV) infection is now a chronic condition due to effective antiretroviral therapy (ART).
- HIV-infected individuals face an elevated risk of premature coronary artery disease (CAD).
- This increased cardiovascular risk is attributed to traditional risk factors, ART, and persistent chronic inflammation.
Purpose of the Study:
- To conduct a comprehensive literature review on the relationship between HIV infection and atherosclerosis.
- To highlight the emerging concern of premature cardiovascular disease in the HIV-positive population.
- To emphasize the need for early detection and aggressive prevention strategies for cardiovascular risk in HIV patients.
Main Methods:
- Systematic review of existing medical literature.
- Analysis of studies focusing on HIV, atherosclerosis, and cardiovascular risk factors.
- Synthesis of data regarding the impact of ART and chronic inflammation on cardiovascular health in HIV patients.
Main Results:
- HIV infection accelerates the development of atherosclerosis and plaque progression.
- Long-term use of antiretroviral therapy (ART) contributes to cardiovascular risk.
- Chronic inflammation associated with HIV infection plays a significant role in premature CAD.
Conclusions:
- HIV-infected patients are at high risk for premature coronary artery disease.
- Early identification of subclinical atherosclerosis is essential in this population.
- Multidisciplinary teams must implement aggressive primary and secondary cardiovascular prevention strategies for HIV patients.
Abstract:
HIV-infected patients are known to be at risk for premature coronary artery disease. This emerging paradigm is a rising concern for clinicians. Due to advances in the treatment of HIV, this once fatal infection has been transformed into a chronic illness. Traditional risk factors paired with the long-term use of antiretroviral therapy (ART) and chronic inflammation leads to premature atherosclerosis, particularly progression of atherosclerotic plaque. This population of patients requires early recognition of subclinical atherosclerosis, as well aggressive primary and secondary prevention strategies among the multi-disciplinary team of physicians caring for them. We sought to present a comprehensive review of the available literature related to HIV and atherosclerosis and cardiovascular risk.
More Related Videos
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
09:41Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies